Are you looking for samples from TSC patients to use in your lab? The TSC Biosample Repository has a growing collection of samples that are tied to phenotypic data. In most cases, we can ship these samples at no charge to the investigator. By the end of May 2019, we have shipped 749 samples for use in diverse projects, ranging from quantification of sphingolipids in plasma to investigating mitochondrial DNA heteroplasmy. As of May 31, 2019, the TSC Biosample Repository has collected: 349 buccal cell samples for DNA isolation 237 blood samples from which plasma and white blood cells have…
The 2019 Dup15q Alliance Science Symposium will be held July 17-18 at the Royal Sonesta in Houston Texas. Learn More
Register now for the 2019 International Tuberous Sclerosis Complex Research Conference: Changing the Course of TSC. We look forward to seeing you June 20-22 at the Chelsea Hotel Toronto! The 2019 conference will be presented by the TS Alliance in partnership with Tuberous Sclerosis Canada Sclérose Tubéreuse and the TS Alliance of Mexico. Learn More View the Agenda
The Congressionally Directed Medical Research Programs (CDMRP) invites the research community to view recordings of its webinar series on funding opportunities that have a team science component. The series will provide an overview of types of award mechanisms that encourage multiple investigators, key elements of team science program announcements, required application documents, and general guidance for applicants. Find the webinar recordings here: https://cdmrp.army.mil/pubs/Webinars/webinar_series Questions: firstname.lastname@example.org
The Tuberous Sclerosis Complex Research Program (TSCRP) is now accepting Pre-Applications for the fiscal year 2019 grant cycle.
The LAM Foundation is accepting letters of intent for its grants program until June 15 at 11:59 p.m. US Central Time. Their mechanisms include a Pilot and Feasibility Grant, a Career Development Research Grant, and an Established Investigator Research Grant.
The TSC Preclinical Consortium invites nominations of compounds to test in one of four animal models relevant to TSC. The deadline for nominations has been extended to July 30. Epilepsy (spontaneous): Tsc1flox/flox;GFAP-Cre+ (GFAP-Tsc1-CKO) mice Epilepsy (spontaneous): in utero electroporated RhebCA mice from Angelique Bordey’s lab Tumor (graft): 105K (Tsc2-null) mouse cell grafts in mice Tumor (spontaneous): Tsc2+/- A/J mouse renal cystadenoma model